Ainsleym we will get human safety data in the next 3 weeks. Just plain stupid on a 20 million market cap how you have a drug biotech company that has been proven over multiple indications in a 60 billion dollar unmet no competition market that revolutionises the way it targets calcium inhibition in the brain and heart and the only drug now to target secondary brain injury which is dosed over multiple days
Human safety results in 3 weeks once that’s ticked off for the first cohort we are well on our way in becoming a billion dollar plus market cap in the years to come as each major milestone is ticked off
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)